ABVC BioPharma shareholders approve reverse stock split authority up to 1-for-15

ABVC BIOPHARMA, INC.

Special meeting held July 7, 2023; quorum of 19,044,974 shares (57.57% voting power) present.
Proposal approved with 18,631,480 votes for, 413,494 against, 0 abstentions.
Board authorized to effect one or more reverse splits up to 1-for-15 at any time before July 7, 2024.
Company intends to implement a reverse split in the near future; will file a subsequent 8-K.
No further details on split ratio or timing provided.

item 5.07 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ABVC BIOPHARMA, INC. shareholders approved Reverse stock split authorization at the 2023-07-07 meeting.

Proposal: reverse split
Outcome: passed
Meeting: 2023-07-07

Exact text from the filing

To approve granting the Board the authority to effect one or more reverse splits of the Company’s issued and outstanding Common Stock by a ratio of up to one-for-fifteen, at any time or from time to time, prior to July 7, 2024, with the exact timing and amount of each split to be determined by the Board in its sole discretion and file a Certificate of Amendment to the Company’s Articles of Incorporation regarding same.

View on SEC.gov

Browse all shareholder votes →

ABVC BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0001213900-23-055559

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.